Product Information
EQUETRO 300 MG CAPSULE is a brand product labeled by Validus Pharmaceuticals LLC, priced at $4.6997 per EA under NDC 30698042312. Its NADAC has been published 240 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Carbamazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Validus Pharmaceuticals LLCNDC
30698042312
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CARBAMAZEPINEApproval Type
New Drug (NDA)
FDA Application
NDA021710On Market Since
12/10/2004
Pharmacological Classes
Price Statistics
The NADAC for EQUETRO 300 MG CAPSULE has been published 240 times since Nov 28, 2013, and over the history we have for it it has risen 102.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6997 per EA |
|---|---|
| All-time high | $4.7197 (Jul 10, 2024) |
| All-time low | $2.3199 (Nov 28, 2013) |
| 52-week high | $4.6999 |
| 52-week low | $4.6640 |
| Median price | $3.3758 |
| Average price | $3.8712 |
| Largest weekly change | +40.0% (May 21, 2014) |
| Weeks tracked | 240 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 77% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EQUETRO 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EQUETRO 300 MG CAPSULE, manufactured by Validus Pharmaceuticals LLC, is $4.6997 per EA (NDC 30698042312), effective Jun 24, 2026.
How has the price of EQUETRO 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EQUETRO 300 MG CAPSULE has risen 102.6%. It has been tracked across 240 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EQUETRO 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for EQUETRO 300 MG CAPSULE has ranged from a low of $2.3199 (Nov 28, 2013) to a high of $4.7197 (Jul 10, 2024), with a median of $3.3758 per EA.
Are there cheaper alternatives to EQUETRO 300 MG CAPSULE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CARBAMAZEPINE ER 300 MG CAP, is $1.0771 per EA — about 77% below EQUETRO 300 MG CAPSULE.
Who manufactures EQUETRO 300 MG CAPSULE?
EQUETRO 300 MG CAPSULE (NDC 30698042312) is labeled by Validus Pharmaceuticals LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification